1. Home
  2. CERO vs JTAI Comparison

CERO vs JTAI Comparison

Compare CERO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • JTAI
  • Stock Information
  • Founded
  • CERO 2017
  • JTAI 2018
  • Country
  • CERO United States
  • JTAI United States
  • Employees
  • CERO N/A
  • JTAI N/A
  • Industry
  • CERO
  • JTAI Blank Checks
  • Sector
  • CERO
  • JTAI Finance
  • Exchange
  • CERO Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • CERO 8.4M
  • JTAI 7.1M
  • IPO Year
  • CERO N/A
  • JTAI N/A
  • Fundamental
  • Price
  • CERO $1.79
  • JTAI $6.59
  • Analyst Decision
  • CERO
  • JTAI
  • Analyst Count
  • CERO 0
  • JTAI 0
  • Target Price
  • CERO N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • CERO 745.6K
  • JTAI 13.3M
  • Earning Date
  • CERO 03-04-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • CERO N/A
  • JTAI N/A
  • EPS Growth
  • CERO N/A
  • JTAI N/A
  • EPS
  • CERO N/A
  • JTAI N/A
  • Revenue
  • CERO N/A
  • JTAI $15,028,926.00
  • Revenue This Year
  • CERO N/A
  • JTAI $21.49
  • Revenue Next Year
  • CERO N/A
  • JTAI $10.05
  • P/E Ratio
  • CERO N/A
  • JTAI N/A
  • Revenue Growth
  • CERO N/A
  • JTAI 46.66
  • 52 Week Low
  • CERO $1.57
  • JTAI $2.30
  • 52 Week High
  • CERO $1,095.00
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • CERO 36.41
  • JTAI 58.27
  • Support Level
  • CERO $1.70
  • JTAI $3.90
  • Resistance Level
  • CERO $2.10
  • JTAI $11.77
  • Average True Range (ATR)
  • CERO 0.23
  • JTAI 1.29
  • MACD
  • CERO 0.23
  • JTAI 0.65
  • Stochastic Oscillator
  • CERO 33.85
  • JTAI 45.30

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: